CD19 and B-cell chronic lymphocytic leukemia: The European Research Initiative for CLL (ERIC) has developed a gold standard flow cytometry assay that combines 8 antibodies, namely, antibodies against CD5, CD3, CD19, CD20, CD22, CD43, CD79b, and CD81 (126).